Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions  
 
A service of the U.S. National Library of Medicine®
Home   What's New   Browse   Handbook   Glossary   Resources   About   Help    Search 

Is gene therapy safe?

Gene therapy is under study to determine whether it could be used to treat disease. Current research is evaluating the safety of gene therapy; future studies will test whether it is an effective treatment option. Several studies have already shown that this approach can have very serious health risks, such as toxicity, inflammation, and cancer. Because the techniques are relatively new, some of the risks may be unpredictable; however, medical researchers, institutions, and regulatory agencies are working to ensure that gene therapy research is as safe as possible.

Comprehensive federal laws, regulations, and guidelines help protect people who participate in research studies (called clinical trials). The U.S. Food and Drug Administration (FDA) regulates all gene therapy products in the United States and oversees research in this area. Researchers who wish to test an approach in a clinical trial must first obtain permission from the FDA. The FDA has the authority to reject or suspend clinical trials that are suspected of being unsafe for participants.

The National Institutes of Health (NIH) also plays an important role in ensuring the safety of gene therapy research. NIH provides guidelines for investigators and institutions (such as universities and hospitals) to follow when conducting clinical trials with gene therapy. These guidelines state that clinical trials at institutions receiving NIH funding for this type of research must be registered with the NIH Office of Biotechnology Activities. The protocol, or plan, for each clinical trial is then reviewed by the NIH Recombinant DNA Advisory Committee (RAC) to determine whether it raises medical, ethical, or safety issues that warrant further discussion at one of the RAC's public meetings.

An Institutional Review Board (IRB) and an Institutional Biosafety Committee (IBC) must approve each gene therapy clinical trial before it can be carried out. An IRB is a committee of scientific and medical advisors and consumers that reviews all research within an institution. An IBC is a group that reviews and approves an institution's potentially hazardous research studies. Multiple levels of evaluation and oversight ensure that safety concerns are a top priority in the planning and carrying out of gene therapy research.

For more information about the safety and oversight of gene therapy:

A discussion of the safety concerns surrounding gene therapy research is available in the article Human Gene Therapy: Harsh Lessons, High HopesThis link leads to a site outside Genetics Home Reference. from the September-October 2000 issue of FDA Consumer magazine.

Additional information about the FDA’s role in overseeing the safety of gene therapy research can be found in the fact sheet Human Gene Therapy and The Role of the Food and Drug Administration.This link leads to a site outside Genetics Home Reference.

The NIH provides several resources about its role in the safety of gene therapy research:

Office of Biotechnology ActivitiesThis link leads to a site outside Genetics Home Reference.

Frequently Asked Questions: Recombinant DNA and Gene TransferThis link leads to a site outside Genetics Home Reference.


Next Topic: What are the ethical issues surrounding gene therapy?

Previous Topic: How does gene therapy work?

 
Published: October 8, 2004

Contact NLM Customer ServiceThis link leads to a site outside Genetics Home Reference.
Lister Hill National Center for Biomedical CommunicationsThis link leads to a site outside Genetics Home Reference.
U.S. National Library of MedicineThis link leads to a site outside Genetics Home Reference., National Institutes of HealthThis link leads to a site outside Genetics Home Reference., Department of Health & Human ServicesThis link leads to a site outside Genetics Home Reference.
Freedom of Information ActThis link leads to a site outside Genetics Home Reference. CopyrightThis link leads to a site outside Genetics Home Reference. PrivacyThis link leads to a site outside Genetics Home Reference. AccessibilityThis link leads to a site outside Genetics Home Reference. FirstGov.govThis link leads to a site outside Genetics Home Reference.
Selection Criteria for Web Links
This link leads to a site outside Genetics Home Reference. Indicates a page outside Genetics Home Reference.